Safranal

Safranal at a Glance

Safranal is a monoterpene aldehyde and the molecule most responsible for the distinctive hay-like, warm aroma of saffron (Crocus sativus). It is the principal component of saffron’s volatile oil and, alongside the red pigment crocin and the bitter glycoside picrocrocin, one of the three apocarotenoids that define the spice’s quality under the ISO 3632 grading standard ^{1,12Reference 1Rezaee R · 2013Safranal: from an aromatic natural product to a rewarding pharmacological agentView study →Reference 12García-Rodríguez MV et al. · 2017Comparative evaluation of an ISO 3632 method and an HPLC-DAD method for safranal quantity determination in saffronView study →}.

Its most-studied biological activity is in the central nervous system: in rodents the isolated aldehyde is anxiolytic, sedative-hypnotic, anticonvulsant and antioxidant, and it is one of the saffron constituents proposed to contribute a serotonergic hand to the plant’s antidepressant effect ^{1,2,8Reference 1Rezaee R · 2013Safranal: from an aromatic natural product to a rewarding pharmacological agentView study →Reference 2Hosseinzadeh H · 2009AnimalAnxiolytic and hypnotic effect of Crocus sativus aqueous extract and its constituents, crocin and safranal, in miceView study →Reference 8Matraszek-Gawron R et al. · 2022Current Knowledge of the Antidepressant Activity of Chemical Compounds from Crocus sativus LView study →}. The important caveat is the compound-page discipline: nearly all of this evidence is preclinical and on the isolate, while the human mood evidence — the saffron depression trials — belongs to whole stigma and standardised extracts, not purified safranal ^{9,10Reference 9Orio L et al. · 2020Antianhedonic and Antidepressant Effects of Affron, a Standardized Saffron (Crocus sativus L.) ExtractView study →Reference 10Akhondzadeh S et al. · 2005RCTCrocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trialView study →}.

As a reactive aldehyde it also carries a more cautious safety note than a typical fragrant monoterpene: high doses were teratogenic in mice, and safranal is one of the constituents behind saffron’s traditional high-dose reputation as a uterine stimulant ^{13Reference 13Moallem SA et al. · 2016AnimalEvaluation of teratogenic effects of crocin and safranal, active ingredients of saffron, in miceView study →}.

Safranal’s Signature

Safranal is unusual among aroma molecules because it is largely a product of processing, not of the living plant. In the fresh stigma the dominant compound is the tasteless-to-bitter monoterpene glycoside picrocrocin. As the stigmas are dried and stored, picrocrocin is hydrolysed and dehydrated — enzymatically and thermally — releasing safranal, which is why properly dried and aged saffron smells the way it does and why the aroma develops during post-harvest handling ^{1,11Reference 1Rezaee R · 2013Safranal: from an aromatic natural product to a rewarding pharmacological agentView study →Reference 11Cid-Pérez TS et al. · 2021The Relation between Drying Conditions and the Development of Volatile Compounds in Saffron (Crocus sativus)View study →}. This picrocrocin → safranal conversion is the aroma chemistry at the heart of the spice: safranal is the principal volatile of the essential oil and the ISO 3632 marker measured (by UV absorbance at 330 nm, or by HPLC) to grade aromatic strength ^{11,12Reference 11Cid-Pérez TS et al. · 2021The Relation between Drying Conditions and the Development of Volatile Compounds in Saffron (Crocus sativus)View study →Reference 12García-Rodríguez MV et al. · 2017Comparative evaluation of an ISO 3632 method and an HPLC-DAD method for safranal quantity determination in saffronView study →}.

The second half of safranal’s signature is its CNS profile. The anxiolytic, sedative-hypnotic and anticonvulsant effects of the isolate in rodents run largely through the GABA-A–benzodiazepine receptor complex — its anticonvulsant protection is abolished by the benzodiazepine-site antagonist flumazenil ^{3Reference 3Hosseinzadeh H · 2007AnimalProtective effect of safranal on pentylenetetrazol-induced seizures in the rat: involvement of GABAergic and opioids systemsView study →} — a mechanism distinct from the serotonergic route of the fellow fragrant monoterpene linalool ^{2,3Reference 2Hosseinzadeh H · 2009AnimalAnxiolytic and hypnotic effect of Crocus sativus aqueous extract and its constituents, crocin and safranal, in miceView study →Reference 3Hosseinzadeh H · 2007AnimalProtective effect of safranal on pentylenetetrazol-induced seizures in the rat: involvement of GABAergic and opioids systemsView study →}. Layered on top is a proposed serotonergic contribution to saffron’s antidepressant action: safranal is one of several Crocus constituents thought to modulate serotonin (and dopamine) neurotransmission, though here the demonstrated clinical effect is the whole plant’s, not the isolate’s ^{8,10Reference 8Matraszek-Gawron R et al. · 2022Current Knowledge of the Antidepressant Activity of Chemical Compounds from Crocus sativus LView study →Reference 10Akhondzadeh S et al. · 2005RCTCrocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trialView study →}. In short: born from picrocrocin, it carries saffron’s smell — and much of saffron’s mood and antioxidant story travels with it.

What It's Used For

Safranal’s preclinical signal is real and reasonably coherent, but the load-bearing caveat repeats throughout: it is almost entirely rodent and in-vitro work on the isolated aldehyde, and the marquee human evidence for saffron’s mood effects is the plant/extract, not this molecule ^{1,9,10Reference 1Rezaee R · 2013Safranal: from an aromatic natural product to a rewarding pharmacological agentView study →Reference 9Orio L et al. · 2020Antianhedonic and Antidepressant Effects of Affron, a Standardized Saffron (Crocus sativus L.) ExtractView study →Reference 10Akhondzadeh S et al. · 2005RCTCrocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trialView study →}.

Evidence by IndicationStrength of support · Beta

Support is an experimental score — weighted by study type (human > animal > in vitro) and volume. A beta, not a validated metric. Human efficacy data are the plant/extract, not the isolate, so isolate scores stay modest by design.

01Anxiolytic / Sedative-HypnoticShaky42%Rodent isolate; safranal (not crocin) active; GABA-A–benzodiazepine mechanism ^{2,3Reference 2Hosseinzadeh H · 2009AnimalAnxiolytic and hypnotic effect of Crocus sativus aqueous extract and its constituents, crocin and safranal, in miceView study →Reference 3Hosseinzadeh H · 2007AnimalProtective effect of safranal on pentylenetetrazol-induced seizures in the rat: involvement of GABAergic and opioids systemsView study →}

02AnticonvulsantShaky34%Rat isolate; PTZ and absence-seizure models; flumazenil-reversible ^{3,4Reference 3Hosseinzadeh H · 2007AnimalProtective effect of safranal on pentylenetetrazol-induced seizures in the rat: involvement of GABAergic and opioids systemsView study →Reference 4Sadeghnia HR et al. · 2008Antiabsence effects of safranal in acute experimental seizure models: EEG and autoradiographyView study →}

03Antioxidant / NeuroprotectiveShaky32%Rat isolate (ischaemia, hyperthyroidism) + systematic review ^{5,6,7Reference 5Hosseinzadeh H · 2005AnimalSafranal, a constituent of Crocus sativus (saffron), attenuated cerebral ischemia induced oxidative damage in rat hippocampusView study →Reference 6Nanda S · 2021Systematic reviewThe role of Safranal and saffron stigma extracts in oxidative stress, diseases and photoaging: A systematic reviewView study →Reference 7Shahat AS et al. · 2022AnimalN-Acetylcysteine and Safranal prevented the brain damage induced by hyperthyroidism in adult male ratsView study →}

04Antidepressant (Serotonergic Contribution)Shaky24%Proposed isolate role; demonstrated effect is whole saffron / extract ^{8,9,10Reference 8Matraszek-Gawron R et al. · 2022Current Knowledge of the Antidepressant Activity of Chemical Compounds from Crocus sativus LView study →Reference 9Orio L et al. · 2020Antianhedonic and Antidepressant Effects of Affron, a Standardized Saffron (Crocus sativus L.) ExtractView study →Reference 10Akhondzadeh S et al. · 2005RCTCrocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trialView study →}

Mechanisms

The GABAergic finding is the anchor: flumazenil abolishes safranal’s anticonvulsant protection, and the same mechanism plausibly underlies its anxiolytic and sedative effects ^{3Reference 3Hosseinzadeh H · 2007AnimalProtective effect of safranal on pentylenetetrazol-induced seizures in the rat: involvement of GABAergic and opioids systemsView study →}. The serotonergic antidepressant story is real biology for saffron, but sits off the safranal-isolate axis ^{8Reference 8Matraszek-Gawron R et al. · 2022Current Knowledge of the Antidepressant Activity of Chemical Compounds from Crocus sativus LView study →}.

Pharmacokinetics

Dedicated human pharmacokinetics for isolated safranal are not established. As a small, lipophilic, volatile aldehyde it is expected to be readily absorbed and to cross the blood–brain barrier — consistent with its central effects after peripheral dosing in rodents ^{3,5Reference 3Hosseinzadeh H · 2007AnimalProtective effect of safranal on pentylenetetrazol-induced seizures in the rat: involvement of GABAergic and opioids systemsView study →Reference 5Hosseinzadeh H · 2005AnimalSafranal, a constituent of Crocus sativus (saffron), attenuated cerebral ischemia induced oxidative damage in rat hippocampusView study →} — but robust absorption, distribution, metabolism and elimination data (Cmax, oral bioavailability, half-life, active metabolites) for the purified compound are lacking. Two practical consequences follow: (1) its volatility means a meaningful share of real-world exposure is olfactory/aromatic rather than systemic; and (2) because human intake is via saffron or standardised extracts, the relevant kinetics are those of the whole preparation, in which safranal is only one of several co-absorbed apocarotenoids ^{1Reference 1Rezaee R · 2013Safranal: from an aromatic natural product to a rewarding pharmacological agentView study →}.

Clinical Trials

There are no controlled efficacy trials of isolated safranal. The human evidence is for whole saffron (e.g. depression RCTs at ~30 mg/day) and standardised extracts standardised to combined safranal + crocin content, not the purified aldehyde ^{9,10Reference 9Orio L et al. · 2020Antianhedonic and Antidepressant Effects of Affron, a Standardized Saffron (Crocus sativus L.) ExtractView study →Reference 10Akhondzadeh S et al. · 2005RCTCrocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trialView study →}.

Last checked: July 2026.

Isolate vs. Plant Studies

This molecule shows the split cleanly. The mechanistic and behavioural work is the isolated aldehyde in rodents: the anxiolytic/hypnotic study that singled out safranal over crocin ^{2Reference 2Hosseinzadeh H · 2009AnimalAnxiolytic and hypnotic effect of Crocus sativus aqueous extract and its constituents, crocin and safranal, in miceView study →}, the PTZ and absence-seizure anticonvulsant work ^{3,4Reference 3Hosseinzadeh H · 2007AnimalProtective effect of safranal on pentylenetetrazol-induced seizures in the rat: involvement of GABAergic and opioids systemsView study →Reference 4Sadeghnia HR et al. · 2008Antiabsence effects of safranal in acute experimental seizure models: EEG and autoradiographyView study →}, and the hippocampal ischaemia antioxidant study ^{5Reference 5Hosseinzadeh H · 2005AnimalSafranal, a constituent of Crocus sativus (saffron), attenuated cerebral ischemia induced oxidative damage in rat hippocampusView study →} all tested purified safranal directly — a genuine preclinical strength. The human efficacy evidence points the other way: saffron’s antidepressant trials used whole dried stigma ^{10Reference 10Akhondzadeh S et al. · 2005RCTCrocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trialView study →}, and the supporting extract work used affron, standardised to combined safranal + crocin content rather than isolated safranal ^{9Reference 9Orio L et al. · 2020Antianhedonic and Antidepressant Effects of Affron, a Standardized Saffron (Crocus sativus L.) ExtractView study →}. The correct framing is therefore: solid isolate mechanism + meaningful clinical evidence for the plant/extract + no direct human isolate efficacy — the two are not interchangeable, and saffron’s benefit cannot be reduced to safranal alone ^{1,8Reference 1Rezaee R · 2013Safranal: from an aromatic natural product to a rewarding pharmacological agentView study →Reference 8Matraszek-Gawron R et al. · 2022Current Knowledge of the Antidepressant Activity of Chemical Compounds from Crocus sativus LView study →}.

Prevalence in Nature

Safranal is, for practical purposes, saffron-specific. It is the principal volatile of dried Crocus sativus stigma and commonly the single largest component of its essential oil (reported roughly 30–70% of the volatile fraction, varying with provenance, drying and storage) ^{1,11Reference 1Rezaee R · 2013Safranal: from an aromatic natural product to a rewarding pharmacological agentView study →Reference 11Cid-Pérez TS et al. · 2021The Relation between Drying Conditions and the Development of Volatile Compounds in Saffron (Crocus sativus)View study →}. Crucially, it is largely absent from the fresh stigma and forms during post-harvest drying from its precursor picrocrocin ^{11Reference 11Cid-Pérez TS et al. · 2021The Relation between Drying Conditions and the Development of Volatile Compounds in Saffron (Crocus sativus)View study →}. Outside saffron and saffron-flavoured foods it is scarce — a few scattered reports in other Crocus species and processed products — which is why safranal serves as an authenticity and quality marker for the spice rather than a widespread plant volatile ^{1,12Reference 1Rezaee R · 2013Safranal: from an aromatic natural product to a rewarding pharmacological agentView study →Reference 12García-Rodríguez MV et al. · 2017Comparative evaluation of an ISO 3632 method and an HPLC-DAD method for safranal quantity determination in saffronView study →}.

Discovery & Synthesis

Safranal was identified in the early twentieth century as the compound responsible for saffron’s characteristic odour, and it has been studied as a distinct pharmacological agent for roughly the eight decades since its structure was established as the essential oil’s main component ^{1Reference 1Rezaee R · 2013Safranal: from an aromatic natural product to a rewarding pharmacological agentView study →}. Its origin in the plant material is a degradation reaction, not primary biosynthesis: safranal is generated from the monoterpene glycoside picrocrocin — itself derived from the carotenoid zeaxanthin via apocarotenoid cleavage — through hydrolysis and dehydration during drying and storage ^{11Reference 11Cid-Pérez TS et al. · 2021The Relation between Drying Conditions and the Development of Volatile Compounds in Saffron (Crocus sativus)View study →}. Manufacture today is chiefly by isolation from saffron volatile oil (and as a defined marker in standardised saffron extracts); safranal is also accessible synthetically as a defined aroma chemical, but commercial interest is dominated by saffron-derived material because its value is tied to the spice.

Patents: not yet researched.

Toxicity & Safety

Safranal carries a moderate flag — higher than a typical fragrant monoterpene — because it is a reactive aldehyde with dose-dependent toxicity and a documented reproductive-toxicity signal, and because it is one of the constituents behind saffron’s traditional high-dose caution. At culinary and ordinary dietary exposure the risk is low; the concern is concentrated, high-dose intake.

The clearest specific finding is reproductive: in mice, high doses of safranal (and crocin) were teratogenic, producing developmental effects at the top of the range tested ^{13Reference 13Moallem SA et al. · 2016AnimalEvaluation of teratogenic effects of crocin and safranal, active ingredients of saffron, in miceView study →}. This aligns with saffron’s long-documented reputation as a uterine stimulant/emmenagogue at medicinal-to-gram doses — a whole-herb caution that is adjudicated on the saffron monograph, where intake is decided, not on this molecule page. As a general point, “natural aroma compound” does not mean “harmless at any dose”: the concentrated aldehyde is a different exposure from a culinary pinch of saffron.

Safety at a Glance

⚠️ Moderate toxicity

• Low risk at culinary/dietary exposure. As saffron’s principal aroma volatile it has a long history of use in food at trace amounts.
• High-dose reproductive toxicity. Isolated safranal was teratogenic in mice at high doses, and safranal is part of saffron’s high-dose uterine-stimulant reputation — concentrated intake is not established as safe ^{13Reference 13Moallem SA et al. · 2016AnimalEvaluation of teratogenic effects of crocin and safranal, active ingredients of saffron, in miceView study →}.
• Reactive aldehyde. Dose-dependent toxicity at concentrations far above dietary levels; the isolate’s full genotoxicity/repeat-dose toxicology is not comprehensively characterised here.
• Pregnancy is a herb/product-level decision. Human reproductive data for the isolate are limited; pregnancy and lactation caution is set on the saffron monograph, not on this molecule page.
• Additive sedation, in principle. As a GABAergic sedative-anticonvulsant it could in theory compound other CNS depressants; a plausible, poorly-quantified interaction more relevant to concentrated extracts than to dietary saffron ^{2,3Reference 2Hosseinzadeh H · 2009AnimalAnxiolytic and hypnotic effect of Crocus sativus aqueous extract and its constituents, crocin and safranal, in miceView study →Reference 3Hosseinzadeh H · 2007AnimalProtective effect of safranal on pentylenetetrazol-induced seizures in the rat: involvement of GABAergic and opioids systemsView study →}.

Dosage

There is no established or recommended human dose for isolated safranal. The figures in the literature are preclinical rodent research doses and are not convertible to human self-dosing:

Human exposure to safranal is dietary (as a saffron volatile) and via standardised saffron extracts — for example affron, dosed at low mg amounts and defined by combined safranal + crocin content rather than isolated safranal — and via whole saffron in mood trials at roughly 30 mg/day ^{9,10Reference 9Orio L et al. · 2020Antianhedonic and Antidepressant Effects of Affron, a Standardized Saffron (Crocus sativus L.) ExtractView study →Reference 10Akhondzadeh S et al. · 2005RCTCrocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trialView study →}. These are research figures and standardised-product specifications, not a personal recommendation.

References

1. Rezaee R, Hosseinzadeh H (2013). Safranal: from an aromatic natural product to a rewarding pharmacological agent. Iranian Journal of Basic Medical Sciences. https://pubmed.ncbi.nlm.nih.gov/23638289/
2. Hosseinzadeh H, Noraei NB (2009). Anxiolytic and hypnotic effect of Crocus sativus aqueous extract and its constituents, crocin and safranal, in mice. Phytotherapy Research. https://pubmed.ncbi.nlm.nih.gov/19142981/
3. Hosseinzadeh H, Sadeghnia HR (2007). Protective effect of safranal on pentylenetetrazol-induced seizures in the rat: involvement of GABAergic and opioids systems. Phytomedicine. https://pubmed.ncbi.nlm.nih.gov/16707256/
4. Sadeghnia HR, Cortez MA, Liu D, Hosseinzadeh H, Snead OC 3rd (2008). Antiabsence effects of safranal in acute experimental seizure models: EEG and autoradiography. Journal of Pharmacy & Pharmaceutical Sciences. https://pubmed.ncbi.nlm.nih.gov/18801302/
5. Hosseinzadeh H, Sadeghnia HR (2005). Safranal, a constituent of Crocus sativus (saffron), attenuated cerebral ischemia induced oxidative damage in rat hippocampus. Journal of Pharmacy & Pharmaceutical Sciences. https://pubmed.ncbi.nlm.nih.gov/16401389/
6. Nanda S, Madan K (2021). The role of Safranal and saffron stigma extracts in oxidative stress, diseases and photoaging: A systematic review. Heliyon. https://pubmed.ncbi.nlm.nih.gov/33615006/
7. Shahat AS, Hassan WA, El-Sayed WM (2022). N-Acetylcysteine and Safranal prevented the brain damage induced by hyperthyroidism in adult male rats. Nutritional Neuroscience. https://pubmed.ncbi.nlm.nih.gov/32264788/
8. Matraszek-Gawron R, Chwil M, Terlecki K, Skoczylas MM (2022). Current Knowledge of the Antidepressant Activity of Chemical Compounds from Crocus sativus L. Pharmaceuticals (Basel). https://pubmed.ncbi.nlm.nih.gov/36678554/
9. Orio L, Alen F, Ballesta A, Martin R, Gomez de Heras R (2020). Antianhedonic and Antidepressant Effects of Affron, a Standardized Saffron (Crocus sativus L.) Extract. Molecules. https://pubmed.ncbi.nlm.nih.gov/32679643/
10. Akhondzadeh S, Tahmacebi-Pour N, Noorbala AA, Amini H, Fallah-Pour H, Jamshidi AH, Khani M (2005). Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trial. Phytotherapy Research. https://pubmed.ncbi.nlm.nih.gov/15852492/
11. Cid-Pérez TS, Nevárez-Moorillón GV, Ochoa-Velasco CE, Navarro-Cruz AR, Hernández-Carranza P, Avila-Sosa R (2021). The Relation between Drying Conditions and the Development of Volatile Compounds in Saffron (Crocus sativus). Molecules. https://pubmed.ncbi.nlm.nih.gov/34834046/
12. García-Rodríguez MV, López-Córcoles H, Alonso GL, Pappas CS, Polissiou MG, Tarantilis PA (2017). Comparative evaluation of an ISO 3632 method and an HPLC-DAD method for safranal quantity determination in saffron. Food Chemistry. https://pubmed.ncbi.nlm.nih.gov/27979282/
13. Moallem SA, Afshar M, Etemad L, Razavi BM, Hosseinzadeh H (2016). Evaluation of teratogenic effects of crocin and safranal, active ingredients of saffron, in mice. Toxicology and Industrial Health. https://pubmed.ncbi.nlm.nih.gov/24097366/

View all 13 references▾